Locations
About
Dr. Valerie Carlberg is a board-certified dermatologist and fellowship-trained pediatric dermatologist specializing in the care of infants, children, and adolescents. She has a special interest in caring for dermatologic conditions in children with cancer as well as cancer survivors. Having trained at the Dana Farber Cancer Institute in Boston and the Seattle Cancer Care Alliance, her expertise includes the diagnosis and management of skin, hair, and nail conditions that result from chemotherapy, targeted therapy, immunotherapy, radiation, transplant, or immunosuppression. This includes graft versus host disease, reactions from medications, infections, and secondary skin cancers. Dr. Carlberg also has advanced procedural training and performs dermatologic surgery and laser surgery to treat congenital and acquired skin lesions such as melanocytic nevi (moles), cysts, vascular malformations (port wine stains), and scars. Finally, Dr. Carlberg is committed to continued education, teaching, and collaborative research to further improve the care of current and future patients.
Certifications
- Pediatric Dermatology
- Dermatology
Education
- 2013, Oregon Health & Science University, MD
Residencies
- 2017, Massachusetts General Hospital - Dermatology
- 2017, Harvard Medical School (Boston, MA) - Dermatology
Fellowships
- 2018, Seattle Children's Hospital - Pediatric Dermatology
Conditions and Treatments
Insurance Information
Aetna*
The Alliance Employer Health Care Cooperative
America's PPO
Anthem Wisconsin*
Aspirus Health Plan
Centivo
Chorus Community Health Plans
Cigna Health Plan
Common Ground
First Health Network by Coventry
Health Partners
Health Payment Systems
HealthEOS
iCare Wisconsin
Managed Health Services (MHS)
Medicaid Wisconsin
Medicare
Molina Healthcare
Multiplan (wrap network only)
Network Health Plan*
OAN EverPointe Elite
Private Health Care Systems (PHCS)
Sheboygan Employer's Health Network (SEHN)
Trilogy Health Networks
TriWest
UnitedHealthcare*
USA Managed Care Organization
Wisconsin Crime Victims Compensation Program
WPS Statewide PPO
Ratings and Reviews
4.8
Overall Parent and Patient Rating
See What Parents and Patients are Saying:
Dr. Carlberg was wonderful and spoke with the patient and not just the parent. Appreciated her explanation of the different treatment options and when to follow up.
She's very personable and really good with my daughter.
They were knowledgeable and caring
Dr.Carlberg is kind and caring. She listens, has excellent feedback and is very supportive.
The care and knowledge that everyone has brought to us has been incredible
Research and Publications
Publications
Manuscripts in Refereed Journals:
Steen AJ, Mann JA, Carlberg VM, Kimball AB, Musty MJ, Simpson EL. Understanding the cost of dermatologic care: A survey study of dermatology providers, residents, and patients. J Am Acad Dermatol. 2017 Apr;76(4):609-617.
Chen C, Carlberg V, Kroshinsky D. Angioedema following squaric acid treatment in a 6-year-old girl. Pediatr Dermatol. Pediatr Dermatol. 2017 Jan;34(1):e44-e46.
Lee JJ, Girouard SD, Carlberg VM, Mostaghimi A. Effective Use of Mirtazapine for Refractory Pruritus Associated with Carcinoma en Cuirasse. BMJ Supportive & Palliative Care. 2016 Mar;6(1):119-21.
Sengle G, Carlberg V, Tufa SF, Charbonneau NL, Smaldone S, Carlson EJ, Ramirez F, Keene DR, Sakai LY. Abnormal Activation of BMP Signaling Causes Myopathy in Fbn2 Null Mice. PLoS Genet. 2015;11(6):e1005340.
Carlberg VM, Lofgren SM, Mann JA, Austin JP, Nolt D, Davila-Saldana B, Shereck EB, Zonana J, Krol AL. Hypohidrotic Ectodermal Dysplasia, Osteopetrosis, Lymphedema, and Immunodeficiency (OL-HED-ID) in an Infant with Multiple Opportunistic Infections. Pediatr Dermatol. 2014 Nov-Dec;31(6):716-21.
Charbonneau NL, Carlson EJ, Tufa S, Sengle G, Manalo EC, Carlberg VM, Ramirez F, Keene DR, Sakai LY. In vivo studies of mutant fibrillin-1 microfibrils. J Biol Chem. 2010; Aug 6;285(32):24943-55.
Sakai LY, Sengle G, Charbonneau NL, Carlberg VM. Extracellular regulation of growth factor signaling by fibrillin microfibrils. FASEB J. 2009;23:309.3.